Vulnerability · Published Jan 19, 2021 · Assigned by icscert
CVE-2020-27269
Medium 5.7
In plain English
A medium-severity security flaw in SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i and AnyDana-A. There are no confirmed reports of exploitation so far. The chance it is exploited in the next 30 days is estimated at 0.5% (higher than 43% of all known vulnerabilities).
Severity (CVSS NVD)5.7Medium
Exploit odds (30 days)0.5%top 56.6% of all CVEs
Exploited in the wildNo reportsnot in CISA KEV
Attack toolingNoneno public tooling known
Official description
In SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i and AnyDana-A, the communication protocol of the insulin pump and its AnyDana-i and AnyDana-A mobile applications lacks replay protection measures, which allows unauthenticated, physically proximate attackers to replay communication sequences via Bluetooth Low Energy.
Affected products (as reported)
| Vendor | Product | Versions |
|---|---|---|
| n/a | SOOIL Developments Co., Ltd Diabecare RS, AnyDana-i and AnyDana-A | Dana Diabecare RS, AnyDana-i, AnyDana-A All versions prior to 3.0 |
Weakness: CWE-294
References
- https://us-cert.cisa.gov/ics/advisories/icsma-21-012-01 x_refsource_MISC